Ajanta Pharma Limited
Ajanta Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: AJANTPHARM and BSE: 532331 (ISIN INE031B01049).
It has a market capitalisation of ₹41,352 crore, a last close of ₹3,299 on 2026-10-19, a one-year return of 35.3%.
Valuation: a price-to-earnings ratio of 36.57x, a price-to-book ratio of 9.13x, a dividend yield of 1.8%.
Profitability: return on equity of 25.4%, return on capital employed of 31.8%, an operating margin of 25.4%.
Growth: sales growth of 13.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.05x, promoter holding of 63.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 41,352 |
| Last close | ₹3,299 |
| P/E (TTM) | 36.57x |
| P/B | 9.13x |
| Dividend yield | 1.8% |
| ROE (FY) | 25.4% |
| ROCE (FY) | 31.8% |
| Operating margin (TTM) | 25.4% |
| Sales growth, 3-year CAGR | 13.4% |
| Debt / equity | 0.05x |
| Promoter holding | 63.5% |
| 1-year return | 35.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means